Abstract |
The present study reports a case of percutaneous sclerotherapy of a giant mediastinal cystic lymphangioma using Ethibloc (Ethicon, Norderstedt, Germany) and absolute ethanol in a 59-yr-old female. The tumour, situated predominantly in a retrocardiac location, caused dyspnoea and dysphagia by compression and was considered unresectable. Follow-up computed tomography 3 yrs after treatment showed a 90% volume reduction of the tumour. The patient is currently asymptomatic. To the best of the present authors' knowledge, percutaneous transthoracic sclerotherapy of a mediastinal lymphangioma has not previously been reported in the literature available in English.
|
Authors | A Desir, B Ghaye, B Duysinx, R F Dondelinger |
Journal | The European respiratory journal
(Eur Respir J)
Vol. 32
Issue 3
Pg. 804-6
(Sep 2008)
ISSN: 1399-3003 [Electronic] England |
PMID | 18757704
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Drug Combinations
- Fatty Acids
- Propylene Glycols
- Sclerosing Solutions
- Diatrizoate
- Zein
- alcoholic prolamine solution
|
Topics |
- Diatrizoate
(therapeutic use)
- Drug Combinations
- Fatty Acids
(therapeutic use)
- Female
- Humans
- Lymphangioma, Cystic
(pathology, therapy)
- Magnetic Resonance Imaging
- Mediastinal Neoplasms
(pathology, therapy)
- Middle Aged
- Propylene Glycols
(therapeutic use)
- Sclerosing Solutions
(therapeutic use)
- Sclerotherapy
- Tomography, Spiral Computed
- Zein
(therapeutic use)
|